Airway structure and airflow help determine which respiratory regions an inhaled medicine can reach. Air moves through the nasal passages, bronchi, and smaller airways, so drug distribution depends on this connected path before the medicine contacts target tissues. These features are therefore important when selecting and developing inhalation approaches for localized respiratory treatment.
Mucus and coordinated ciliary movement can remove inhaled particles and other material from airway surfaces. This clearance process may influence how long a medicine remains near its intended respiratory target and whether it can dissolve there. Pharmacological evaluation must therefore consider clearance alongside airway structure when assessing inhaled drug delivery and expected effects.
Airway epithelial barriers influence how inhaled medicines interact with respiratory tissues after deposition. The medicine must reach the relevant surface and dissolve before producing an effect, while the barrier also helps shape whether effects remain local or become systemic. Understanding this interaction supports interpretation of drug performance and guides inhaled formulation development.
Evaluation should consider airway structure, airflow, epithelial barriers, dissolution, and mucociliary clearance. Together, these factors describe the path from inhalation to contact with target tissues and help explain variation in local or systemic effects. Researchers can use this framework when assessing inhalation devices and determining whether a medicine is likely to reach the intended respiratory region.
Knowledge of the respiratory tract supports the development and use of several inhaled medicine categories, including bronchodilators, corticosteroids, and antimicrobials. The same structural and clearance considerations help determine how these treatments reach respiratory tissues. This makes airway biology relevant both to medicines intended for local respiratory effects and to delivery approaches that may produce systemic effects.
The respiratory tract provides a route through which medicines can contact airway and lung tissues after inhalation. Pharmacology therefore examines how airways conduct particles, how epithelial barriers influence tissue access, and how mucus and cilia affect removal. This knowledge supports rational development and use of inhalation devices, particularly for treatments aimed at respiratory disease.